UMAX Group (UMAX) Stock Overview
A development stage company, doing business as UMAX Nutrition, focuses on developing and distributing natural and organic nutrition, and dietary supplements to the nutritional industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
UMAX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
UMAX Group Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.22 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 3 Year Change | -96.15% |
| 5 Year Change | -99.95% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| UMAX | US Leisure | US Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | -0.1% |
| 1Y | n/a | -4.2% | 16.6% |
Return vs Industry: Insufficient data to determine how UMAX performed against the US Leisure industry.
Return vs Market: Insufficient data to determine how UMAX performed against the US Market.
Price Volatility
| UMAX volatility | |
|---|---|
| UMAX Average Weekly Movement | n/a |
| Leisure Industry Average Movement | 6.9% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: UMAX's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine UMAX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | Gerald Edick | www.umaxcorp.com |
UMAX Group Corp., a development stage company, doing business as UMAX Nutrition, focuses on developing and distributing natural and organic nutrition, and dietary supplements to the nutritional industry. Its product line provides dietary needs for weight loss, colon health, sexual health, body building, and general health and vitality. The company’s products include UPRITE XXL, a natural herbal male enhancement supplement providing an alternative to prescription erectile dysfunction medication; green coffee bean extract; and RASPBERRY KETONE, an anti-oxidant and fat burning ingredient.
UMAX Group Corp. Fundamentals Summary
| UMAX fundamental statistics | |
|---|---|
| Market cap | US$14.09k |
| Earnings (TTM) | -US$120.40k |
| Revenue (TTM) | US$13.50k |
Is UMAX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| UMAX income statement (TTM) | |
|---|---|
| Revenue | US$13.50k |
| Cost of Revenue | US$6.48k |
| Gross Profit | US$7.02k |
| Other Expenses | US$127.41k |
| Earnings | -US$120.40k |
Last Reported Earnings
Oct 31, 2013
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did UMAX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/22 20:55 |
| End of Day Share Price | 2025/10/22 00:00 |
| Earnings | 2013/10/31 |
| Annual Earnings | 2013/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
UMAX Group Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.